Test Price
750 AED✅ Home Collection Available
First Trimester Triple Marker Test – 750 AED | DNA Labs UAE
Executive Summary & Core Metrics
The First Trimester Triple Marker Test is an advanced prenatal screening that assesses maternal serum biomarkers (free β‑hCG, PAPP‑A, PlGF) combined with nuchal translucency ultrasound to calculate individualized risk for trisomy 21, 18, 13 and early‑onset pre‑eclampsia. Available at 750 AED with same-day results (sample before 9 AM on Tuesday, Thursday, Saturday) and VIP mobile phlebotomy home collection (8 AM – 11 PM). DHA-licensed (License 1143) and ISO 9001:2015 certified.
Test Overview & Methodology
This quantitative immunoassay employs electrochemiluminescence detection (ECLIA) to precisely measure free beta‑hCG, pregnancy‑associated plasma protein‑A (PAPP‑A), and placental growth factor (PlGF) in maternal serum. Combined with nuchal translucency ultrasound measurements, the algorithm delivers risk scores for common aneuploidies and pre‑eclampsia. The test is performed in our ISO‑certified, DHA‑licensed laboratory.
| Feature | Our Test (ECLIA Precision) | Closest Alternative |
|---|---|---|
| Methodology | Electrochemiluminescence Immunoassay (ECLIA) | Standard Chemiluminescence Immunoassay (CLIA) only |
| Turnaround Time | Same‑day (sample received before 9 AM Tue/Thu/Sat) | 24–72 hours, often batch‑processed |
| Screening Coverage | Integrated risk for trisomies + pre‑eclampsia in one profile | Separate individual tests; sequential sampling |
| ISO Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May not hold ISO certification |
Physician Insight & Safety Protocols
“Prenatal screening is a risk stratification tool, not a diagnostic conclusion. The First Trimester Triple Marker Test indicates whether further diagnostic steps such as chorionic villus sampling or amniocentesis may be warranted. Always review results with your obstetrician and never base medical decisions solely on a screening report.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication (including antihypertensives, aspirin, or hormonal support) without consulting your doctor. The test results must be interpreted in the context of your ongoing treatment.
Safety Exclusion Criteria & Red Flags
- Test not valid beyond 13 weeks and 6 days of gestation.
- Cannot be interpreted if essential ultrasound data (CRL, NT, nasal bone) is missing or inadequate.
- Haemolysed, icteric or lipaemic samples may lead to rejection.
- Multiple gestation with more than two foetuses requires specialised interpretation outside this panel.
- ER RED FLAGS: Severe abdominal pain, heavy vaginal bleeding, sudden severe swelling of face/hands, or visual disturbances. Seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the First Trimester Triple Marker Test and why is it done?
It analyzes serum PAPP‑A, free beta‑hCG, and optionally PlGF to screen for fetal chromosomal anomalies and early‑onset pre‑eclampsia between 10–13 weeks of gestation.
2. How accurate is this test for Down syndrome and pre‑eclampsia?
Combined with nuchal translucency ultrasound, the detection rate for trisomy 21 exceeds 90% with a 5% false‑positive rate when performed by our ISO‑certified laboratory using ECLIA technology.
3. Do I need to fast or stop supplements before the test?
No fasting is required. Simply provide the completed Maternal Serum Screen Form (Form 11) and Preeclampsia Screening Form (Form 13), along with the mandatory ultrasound report.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
- DHA Facility License: 1143
- ISO 9001:2015 Certification: INT/EGQ/2509DA/3139
- VIP Mobile Phlebotomy Home Collection: Available daily 8 AM – 11 PM with temperature-controlled cold-chain logistics
Clinical & Logistical Metadata
| Test Name | First Trimester Triple Marker Test |
| Price (AED) | 750 |
| Turnaround Time | Same-day (sample received before 9 AM on Tuesday, Thursday, Saturday) |
| Sample Type / Matrix | Maternal Blood Serum (Peripheral Blood) |
| Methodology Used | Electrochemiluminescence Immunoassay (ECLIA) |
| ICD-10-CM Code | Z36.0 |
| LOINC Code | 33914-3 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians